Why a focused question list matters more than a long medical history
Immunotherapy helps the immune system act against cancer, but whether it is appropriate depends on the cancer and individual assessment. That single fact shapes how you should prepare. You are not going to a first meeting to recite every scan since diagnosis. You are going to establish whether this treatment is relevant to your specific disease, what evidence supports it, and what the next step would be.
A long chronological story can bury the decision. A short list of questions tied to tumour type, biomarkers and previous treatment gives the clinician a clear structure to respond to. It also gives you a way to notice when an answer is general rather than specific to your case.
Bring the questions in writing. If you are working through an interpreter, written questions reduce the risk that a key point is softened or skipped. Ask the clinician to answer each one directly, and write down the response while it is fresh.
The five questions that should anchor the conversation
First: is immunotherapy appropriate for my tumour type and stage, and what is that assessment based on? The answer should refer to your pathology and staging records, not to immunotherapy as a general category.
Second: which biomarkers or pathology findings are relevant to this decision, and have they already been tested? Biomarker results can change whether a particular immunotherapy approach is considered. If the test has not been done, ask whether it is needed and who would order it.
Third: how does my previous treatment affect this option? Prior therapy can influence what is considered next. Ask the clinician to explain the reasoning in plain terms.
Fourth: what would the treatment plan look like in practice, including how response would be monitored? Ask which assessments would be used and how often, without assuming a fixed schedule.
Fifth: if treatment starts in China, how would monitoring continue at home? This is often the question patients leave until the end, but it affects whether the plan is realistic for you.
What to bring so the discussion is not based on incomplete information
The clinician can only assess what is in front of them. Bring the pathology report, including any biomarker or molecular results, imaging reports and the actual images if available, a summary of previous treatments with dates and responses, and current medication list. A short typed summary of your treatment history is more useful than a folder of unsorted papers.
If a record is missing, say so at the start rather than hoping the clinician will infer it. Ask whether the missing item changes the assessment and, if so, how it can be obtained. Do not assume that a records-based opinion or a first consultation establishes final eligibility for any treatment.
Language matters here. If your records are in another language, ask in advance whether translation is needed and who will provide it. Do not rely on a family member to translate pathology terms during the appointment unless they are comfortable with medical vocabulary.
Questions about availability and access that only the treating team can answer
Patients often ask whether a specific immunotherapy drug is available in China. That is a hospital and pharmacy question, not something to assume from a general article. Ask the treating team whether the relevant option is available at their institution, what the process would be, and what alternatives exist if it is not.
Availability and suitability are separate questions, and a first discussion may not settle either. The clinician has to weigh your tumour type, biomarker results and prior treatment before saying whether a particular immunotherapy approach is appropriate. Access to a medicine at a given hospital is a further question that the hospital and its pharmacy answer, not something a general article can confirm.
Do not treat a preliminary reply as confirmation of access, scheduling or suitability. A first discussion may end with a request for more records, a recommendation for a different approach, or a decision to review the case further. Each of those is a legitimate outcome, and none of them means the enquiry was wasted.
If the clinician says the option is not available at their institution, ask what they would recommend instead and whether another route is worth exploring. Ask them to put the reasoning in writing if you need it for your home clinician. A verbal answer during a busy clinic can be hard to reconstruct later.
If medicine entry into China is part of your situation, that is a customs question. Customs authorities decide what may be brought in. A clinician or coordination service does not decide it. Ask the relevant authority directly rather than relying on informal advice.
Cost is a separate conversation from suitability. Ask the hospital what its written estimate for the proposed plan includes and what it does not. Do not assume that a quoted figure covers every test, medicine or follow-up visit. The named provider is the only reliable source for its own billing scope, and you can request that scope in writing before you commit to anything.
How to discuss monitoring at home without assuming it will be straightforward
If you are considering treatment in China while living elsewhere, the monitoring plan is not a minor detail. Ask who would be responsible for follow-up assessments, what information would need to be shared with your home clinician, and whether the treating team is willing to communicate with them.
Do not assume that your home clinician will automatically continue a plan designed elsewhere. The receiving clinician makes their own judgement about what they can safely oversee. Ask what records they would need and whether they are willing to take on that role.
Ask the China-based team what they would provide: a treatment summary, imaging, laboratory results, or a written plan. Then ask your home clinician what they would require. The gap between those two answers is where practical problems appear.
The timing of any travel also depends on clinical stability, not on convenience alone. If your symptoms are worsening or you need urgent assessment, that takes priority over an overseas enquiry. Ask the treating clinician whether there is any reason to delay travel for treatment, and follow local medical advice first.
If you are already on treatment, ask how a move to China would affect continuity. Would the current regimen be continued, adjusted or paused? Who would make that decision, and what records would they need? Do not stop or change any prescribed treatment on your own.
Ask what would happen if the plan needs to change after you arrive. A treatment plan is not a fixed contract. Response, side effects or new findings can change the recommended approach. Ask how the team communicates changes and how quickly you would be informed.
For patients who need help gathering records, arranging interpretation or requesting a specialist appointment, coordination support can be discussed separately. An initial enquiry is free and does not require buying a proxy consultation. The hospital decides suitability, and no coordination service can promise acceptance or availability.
What a first discussion can and cannot settle
A first in-person discussion can clarify whether immunotherapy is a reasonable direction for your diagnosis, what evidence is missing, and what the next step would be. It cannot guarantee that a treatment will work, that a hospital will accept you, or that a specific drug will be available.
If the clinician recommends immunotherapy, ask what the expected benefit is based on and what uncertainty remains. You are allowed to ask about evidence-based risk and outcome estimates. No estimate guarantees an individual result, but understanding the reasoning helps you decide.
If the recommendation is to continue current care rather than travel, take that seriously. Do not interrupt or delay necessary local treatment for an overseas enquiry. Urgent or worsening symptoms need local assessment first.
After the appointment, write a short summary of what was said, what was decided and what happens next. If you are considering coordination support for records, interpretation or a specialist appointment request, that can be discussed separately. An initial enquiry is free and does not require buying a proxy consultation. The hospital decides suitability.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.